SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Violations of Federal Securi...
July 30 2014 - 4:45PM
Business Wire
Levi & Korsinsky, LLP is investigating Northwest
Biotherapeutics, Inc. (“Northwest Bio” or the “Company”) (NasdaqCM:
NWBO) in connection with possible breaches of federal securities
laws. The investigation regards concerns that the Company made
misleading statements regarding its clinical trial for DC-Vax
Direct, its experimental cancer vaccine.
To get more information, click here:
http://zlk.9nl.com/northwest-biotherapeutics-nwbo. There is
no cost or obligation to you.
On June 19, 2014, an article featured on TheStreet.com alleged
that the MD Anderson Cancer Center had “issued a stern rebuke to
Northwest Biotherapeutics for making promotional, unjustified
claims about results” from the ongoing drug trial.
If you own common stock in Northwest Bio and wish to obtain
additional information, please contact Eduard Korsinsky, Esq.
either via email at ek@zlk.com or by telephone at (212) 363-7500,
toll-free: (877) 363-5972, or visit
http://zlk.9nl.com/northwest-biotherapeutics-nwbo.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut and Washington D.C. The firm’s 26
attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
Levi & Korsinsky, LLPEduard Korsinsky, Esq.Tel:
212-363-7500Toll Free: 877-363-5972Fax: 866-367-6510www.zlk.com
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Sep 2023 to Sep 2024